NBI-34060
NBI-34060-IR-0702
Phase 3 small_molecule terminated
Quick answer
NBI-34060 for Insomnia is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Insomnia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated